Skip to main content

Advertisement

SpringerLink
Log in

A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer

  • Original Article
  • Published:
Immunogenetics Aims and scope Submit manuscript

Abstract

Gastric cancer (GC) is the third leading cause of global cancer morbidity and mortality. One of the significant challenges in GC treatment is that most GC patients are diagnosed with advanced-stage disease due to the lack of suitable biomarkers. Recent studies have shown that microRNAs (miRNAs) can acts as a potential biomarker in GC diagnosis and prognosis. I performed a systematic review of published miRNA studies in GC, which includes the miRNA expression profiles between GC tissues and normal tissues and also miRNA studies to evaluate their potential value in the diagnosis and prognosis of GC. Among the studies, upregulation of miR-21, miR-106b, miR-25, miR-214, miR-18a, miR-191, and miR-93 and downregulation of miR-375, miR-148a, miR-92, miR-155, and miR-564 were observed in GC tissues. In evaluating of diagnosis value of miRNAs, the study was performed on a combined miRNA include miR-21, miR-93, miR-106a, and miR-106b indicated the panel of these miRNAs have the highest AUC 0.887 to discriminate GC patients from healthy. Also, miR-940 with a sensitivity of 81.25% and specificity of 98.57% may be used for diagnostic biomarkers for GC. Finally, the pooled prognostic result of miR-21 for hazard ratios (HR) was 1.260 (95% CI 0.370–4.330, P < 0.001), showing that miR-21 could predict poor survival in GC patients. This systematic review can confirm that we need to find a miRNA or a panel of miRNAs with high sensitivity and specificity for further exploration to investigate a better diagnostic or therapeutic tool for personalized management of GC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Ahadi A (2020) Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. IUBMB Life 72(5):884–898

    Article  CAS  PubMed  Google Scholar 

  • Ahadi A, Safavi MS (2019) miR-335-5p has an important role in the progression of gastric cancer by down-regulation of CEACAM5. Meta Gene 19:65–68

    Article  Google Scholar 

  • Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132(21):4653–4662

    Article  CAS  PubMed  Google Scholar 

  • Canu V, Mori F, Di Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM, Germoni S, SABF (2012) miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death and Disease 3:e423

  • Chan SK, Griffith OL, Tai IT, Jones SJ (2008) Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Prev Biomarkers 17(3):543–552

    Article  CAS  Google Scholar 

  • Chang L, Guo F, Huo B, Lv Y, Wang Y, Liu W (2015) Expression and clinical significance of the microRNA-200 family in gastric cancer. Oncology letters 9(5):2317–2324

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H, Yu X, Xiao B, Wang W, Guo J (2011) Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. ClinBiochem 44(13):1050–1057

    CAS  Google Scholar 

  • Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, Xiao B, Xia T, Yu X, Le Y (2013) Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 119(9):1618–1626

    Article  CAS  PubMed  Google Scholar 

  • De Val S, Black BL (2009) Transcriptional control of endothelial cell development. Dev Cell 16(2):180–195

    Article  PubMed  PubMed Central  Google Scholar 

  • Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, Yao H, Liu X, Ke Y, Si J (2010) MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20(7):784–793

    Article  CAS  PubMed  Google Scholar 

  • Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269

    Article  CAS  PubMed  Google Scholar 

  • Gillespie P, Ladame S, O’Hare D (2019) Molecular methods in electrochemical microRNA detection. Analyst 144(1):114–129

    Article  CAS  Google Scholar 

  • Griffith OL, Melck A, Jones SJ, Wiseman SM (2006) Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J ClinOncol 24(31):5043–5051

    Article  CAS  Google Scholar 

  • Guan H, Li W, Li Y, Wang J, Li Y, Tang Y, Lu S (2017) MicroRNA-93 promotes proliferation and metastasis of gastric cancer via targeting TIMP2. PLoS ONE 12(12):e0189490

    Article  PubMed  PubMed Central  Google Scholar 

  • Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J GastroenterolHepatol 24(4):652–657

    CAS  Google Scholar 

  • Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO molecular medicine 4(3):143–159

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jemal, A., F. Bray, M. M. Center, J. Ferlay, E. Ward and D. Forman (2011). Global cancer statistics. CA: a cancer journal for clinicians 61(2): 69–90.

  • Jiexian J, Xiaoqin X, Lili D, Baoguo T, Ting S, Xianwen Z, Cunzhi H (2013) Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Int J Biol Marker 28(2):192–200

    Article  Google Scholar 

  • Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE (2011) miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics 4(1):79

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kong Y, Ning L, Qiu F, Yu Q, Cao B (2019) Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer. Cancer Biomark 24(4):477–483

    Article  CAS  PubMed  Google Scholar 

  • Kwok GT, Zhao JT, Weiss J, Mugridge N, Brahmbhatt H, MacDiarmid JA, Robinson BG, Sidhu SB (2017) Translational applications of microRNAs in cancer, and therapeutic implications. Non-coding RNA research 2(3–4):143–150

    Article  PubMed  PubMed Central  Google Scholar 

  • Li B-S, Zhao Y-L, Guo G, Li W, Zhu E-D, Luo X, Mao X-H, Zou Q-M, Yu P-W, Zuo Q-F (2012) Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS ONE 7(7):e41629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li X, Luo F, Li Q, Xu M, Feng D, Zhang G, Wu W (2011) Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol Rep 26(6):1431–1439

    PubMed  Google Scholar 

  • Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu Z, Tang W, Gan L, Sun M, Li J (2015) MicroRNA-940 promotes tumor cell invasion and metastasis by downregulating ZNF24 in gastric cancer. Oncotarget 6(28):25418

    Article  PubMed  PubMed Central  Google Scholar 

  • Liu X, Kwong A, Sihoe A, Chu K-M (2016) Plasma miR-940 may serve as a novel biomarker for gastric cancer. Tumor Biology 37(3):3589–3597

    Article  CAS  PubMed  Google Scholar 

  • Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A (2008) Circulating microRNAs as stable blood-based markers for cancer detection. ProcNatlAcadSci 105(30):10513–10518

    Article  CAS  Google Scholar 

  • Naito Y, Yasuno K, Tagawa H, Sakamoto N, Oue N, Yashiro M, Sentani K, Goto K, Shinmei S, Oo HZ (2014) MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer. Oncol Rep 32(4):1720–1726

    Article  CAS  PubMed  Google Scholar 

  • Oh H-K, Tan AL-K, Das K, Ooi C-H, Deng N-T, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha S-Y (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17(9):2657–2667

    Article  CAS  PubMed  Google Scholar 

  • Saito Y, Suzuki H, Imaeda H, Matsuzaki J, Hirata K, Tsugawa H, Hibino S, Kanai Y, Saito H, Hibi T (2013) The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. Int J Cancer 132(8):1751–1760

    Article  CAS  PubMed  Google Scholar 

  • Shao J, Fang P-H, He B, Guo L-L, Shi M-Y, Zhu Y, Bo P (2016) Downregulated microRNA-133a in gastric juice as a clinicopathological biomarker for gastric cancer screening. Asian Pac J Cancer Prev 17(5):2719–2722

    PubMed  Google Scholar 

  • Shin J-Y, Kim Y-I, Cho S-J, Lee MK, Kook M-C, Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW (2014) MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS ONE 9(1):e85205

    Article  PubMed  PubMed Central  Google Scholar 

  • Shiotani A, Murao T, Kimura Y, Matsumoto H, Kamada T, Kusunoki H, Inoue K, Uedo N, Iishi H, Haruma K (2013) Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer. Br J Cancer 109(9):2323–2330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tchernitsa O, Kasajima A, Schäfer R, Kuban RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert MP (2010) Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol 222(3):310–319

    Article  PubMed  Google Scholar 

  • Torre, L. A., F. Bray, R. L. Siegel, J. Ferlay, J. Lortet‐Tieulent and A. Jemal (2015). Global cancer statistics, 2012. CA: a cancer journal for clinicians 65(2): 87–108.

  • Tsujiura M, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Otsuji E (2014) Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids. World journal of gastroenterology: WJG 20(12):3265

    Article  CAS  PubMed  Google Scholar 

  • Tsujiura M, Komatsu S, Ichikawa D, Shiozaki A, Konishi H, Takeshita H, Moriumura R, Nagata H, Kawaguchi T, Hirajima S (2015) Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer 18(2):271–279

    Article  CAS  PubMed  Google Scholar 

  • Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M (2010) MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3ζ. Can Res 70(6):2339–2349

    Article  CAS  Google Scholar 

  • Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu C-G, Oue N, Yasui W (2010) Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11(2):136–146

    Article  CAS  PubMed  Google Scholar 

  • Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M (2012) Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 10(1):186

  • Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. ProcNatlAcadSci 103(7):2257–2261

    Article  CAS  Google Scholar 

  • Wang H, Wang L, Wu Z, Sun R, Jin H, Ma J, Liu L, Ling R, Yi J, Wang L (2014) Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. Med Oncol 31(12):298

    Article  PubMed  Google Scholar 

  • Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, Zhao C, Tao Y, Xu W (2012) Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep 5(6):1514–1520

  • Wang T, Hou J, Li Z, Zheng Z, Wei J, Song D, Hu T, Wu Q, Yang JY, Cai J-C (2017) miR-15a-3p and miR-16-1-3p negatively regulate Twist1 to repress gastric cancer cell invasion and metastasis. Int J Biol Sci 13(1):122

  • Wu, J., G. Li, Z. Wang, Y. Yao, R. Chen, X. Pu and J. Wang (2015). Circulating microRNA-21 is a potential diagnostic biomarker in gastric cancer. Disease markers 2015.

  • Wu J, Li G, Yao Y, Wang Z, Sun W, Wang J (2015) MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers 20(1):58–63

    Article  CAS  PubMed  Google Scholar 

  • Yamanaka S, Olaru AV, An F, Luvsanjav D, Jin Z, Agarwal R, Tomuleasa C, Popescu I, Alexandrescu S, Dima S (2012) MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Digestive and Liver Disease 44(7):589–596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J, Yang C, Jiang Y (2014) Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 33(2):193–202

    Article  CAS  PubMed  Google Scholar 

  • Yao Y, Suo A-L, Li Z-F, Liu L-Y, Tian T, Ni L, Zhang W-G, Nan K-J, Song T-S, Huang C (2009) MicroRNA profiling of human gastric cancer. Mol Med Rep 2(6):963–970

  • Yu D, Shin H-S, Lee YS, Lee YC (2014) miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells. Lab Invest 94(12):1370–1381

    Article  CAS  PubMed  Google Scholar 

  • Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao X, Zhang X, Cui L, Ye G (2013) Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol 30(1):365

    Article  PubMed  Google Scholar 

  • Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27(4):1019–1026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang X, Cui L, Ye G, Zheng T, Song H, Xia T, Yu X, Xiao B, Le Y, Guo J (2012) Gastric juice microRNA-421 is a new biomarker for screening gastric cancer. Tumor Biology 33(6):2349–2355

    Article  CAS  PubMed  Google Scholar 

  • Zhao G, Jiang T, Liu Y, Huai G, Lan C, Li G, Jia G, Wang K, Yang M (2018) Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer. Bmc Cancer 18(1):676

    Article  PubMed  PubMed Central  Google Scholar 

  • Zheng Y, Cui L, Sun W, Zhou H, Yuan X, Huo M, Chen J, Lou Y, Guo J (2012) MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer biomarkers 10(2):71–77

    Article  Google Scholar 

  • Zhong Z, Dong Z, Yang L, Gong Z (2012) miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J Cancer Res ClinOncol 138(10):1781–1788

    Article  CAS  Google Scholar 

  • Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, Dai J, Ma H, Hu Z, Shen H (2014) A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer 110(9):2291–2299

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Alireza Ahadi

Authors
  1. Alireza Ahadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alireza Ahadi.

Ethics declarations

Conflict of interest

The author declares that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahadi, A. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer. Immunogenetics 73, 155–161 (2021). https://doi.org/10.1007/s00251-020-01201-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00251-020-01201-6

Keywords

Search

Navigation